(Q38501403)

English

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study

scientific article published on May 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Hyun Woong Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Joung Il Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Soon Ho Um

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sang Hoon Ahn

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Hye Young Chang

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Yong Kwang Park

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sun Pyo Hong

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Young Myoung Moon

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kwang-Hyub Han

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

729-735

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Current treatment of chronic hepatitis B: benefits and limitations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Clinical trial results of new therapies for HBV: implications for treatment guidelines

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Thymalfasin for the treatment of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Detection of hepatitis B virus YMDD variants using mass spectrometric analysis of oligonucleotide fragments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Emergence of YMDD motif mutant of hepatitis B virus during short-term lamivudine therapy in South Korea

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Molecular virology and the development of resistant mutants: implications for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Combination of alpha-interferon with lamivudine reduces viral breakthrough during long-term therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Interferon-alpha plus lamivudine vs lamivudine reduces breakthroughs, but does not affect sustained response in HBeAg negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Hepatitis B genotypes and the response to interferon therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2008.05387.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2008.05387.X

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38501403&oldid=2127925396"